Increasingly, biotechnology companies are becoming more engaged in developing products targeting neglected tropical diseases. Despite diverse technology platforms and distinct business models, each of the companies represented on this panel has conceived and implemented a unique global health strategy for applying their technologies to neglected tropical diseases. Panelists will discuss their global health programs, how they decided to become engaged, why they chose their strategy and partners and the hurdles they face.

• Understand new economic drivers that make neglected tropical diseases an attractive opportunity for biotech companies
• Discuss new and unique business models employed by the biotechnology industry in neglected tropical diseases
• Challenge the audience to consider ways they can develop their own global health strategies